Seniors who got a high-dose flu vaccine had a nearly 55% reduced risk of Alzheimer’s, researchers reported earlier this month ...

High-dose vaccine tied to roughly 20% lower risk of Alzheimer's dementia ...

From updated cholesterol targets to a possible Alzheimer's link with flu vaccines, here's what you need to know to protect ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...

Vaccine effectiveness against hospitalization ranged from 28% during the 2021-2022 flu season to 67% in the 2023-2024 season ...

CLEVELAND, Ohio — This season’s influenza vaccine may have been less effective than last season’s, because it was not well matched against the flu strains in circulation, according to an analysis by ...

Adults aged 65 and older receiving high-dose influenza vaccine show a lower risk for Alzheimer dementia compared with those receiving standard doses.

A study by Massachusetts General Hospital found that older adults who got the high-dose flu vaccine had 20% lower Alzheimer's and related dementia than those who received standard flu vaccines.

The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

These findings point to a significant weakness in long-term flu immunity. H3 strains, including H3N2, remain a major cause of seasonal outbreaks, yet the older vaccine offered minimal defense against ...

The global influenza vaccines market is projected to reach USD 13.46 billion by 2031, growing at a CAGR of 7.49%, led by North America, with Asia-Pacific emerging as a high-growth region driven by ...